A Retrospective Study to Assess 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea
Latest Information Update: 12 Sep 2022
Price :
$35 *
At a glance
- Drugs Mesalazine (Primary) ; Mesalazine (Primary) ; Balsalazide; Balsalazide; Sulfasalazine; Sulfasalazine
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 09 Sep 2022 Status changed from active, no longer recruiting to completed.
- 26 Jul 2022 Planned End Date changed from 14 Jun 2022 to 31 Jul 2022.
- 26 Jul 2022 Planned primary completion date changed from 14 Jun 2022 to 31 Jul 2022.